temozolomide has been researched along with Granulocytic Leukemia, Chronic in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients (16 with acute myelogenous leukemia, two with acute lymphoblastic leukemia, and two with chronic myelogenous leukemia in blastic phase) received 43 cycles of temozolomide." | 5.10 | Phase I study of temozolomide in relapsed/refractory acute leukemia. ( Ahmed, T; Baskind, P; Liu, D; Loughran, T; Seiter, K; Siddiqui, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seiter, K | 1 |
| Liu, D | 1 |
| Loughran, T | 1 |
| Siddiqui, A | 1 |
| Baskind, P | 1 |
| Ahmed, T | 1 |
| De Vita, S | 1 |
| De Matteis, S | 1 |
| Laurenti, L | 1 |
| Chiusolo, P | 1 |
| Reddiconto, G | 1 |
| Fiorini, A | 1 |
| Leone, G | 1 |
| Sica, S | 1 |
| Katsoulas, A | 1 |
| Rachid, Z | 1 |
| McNamee, JP | 1 |
| Williams, C | 1 |
| Jean-Claude, BJ | 1 |
| Deans, B | 1 |
| Tisdale, MJ | 1 |
| Zucchetti, M | 1 |
| Catapano, CV | 1 |
| Filippeschi, S | 1 |
| Erba, E | 1 |
| D'Incalci, M | 1 |
1 trial available for temozolomide and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Phase I study of temozolomide in relapsed/refractory acute leukemia.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Dose-Response Relationship, Drug; Drug | 2002 |
4 other studies available for temozolomide and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Secondary Ph+ acute lymphoblastic leukemia after temozolomide.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherap | 2005 |
Combi-targeting concept: an optimized single-molecule dual-targeting model for the treatment of chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Dacarbazine; DNA Damage; DNA-Binding Proteins | 2008 |
Antitumour imidazotetrazines XXVIII 3-methyladenine DNA glycosylase activity in cell lines sensitive and resistant to temozolomide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Burkitt Lymphoma; Cell Line; Cell Survival; Chromato | 1992 |
Temozolomide induced differentiation of K562 leukemia cells is not mediated by gene hypomethylation.
Topics: Blotting, Northern; Cell Cycle; Cell Differentiation; Dacarbazine; DNA Damage; DNA, Neoplasm; Flow C | 1989 |